Senate Finance Chair Chuck Grassley (R-IA), at a hearing on the status of the Medicare Access and CHIP Reauthorization Act, said the law’s passage, after 17 patches to the Sustainable Growth Rate system over more than a decade, shows lawmakers could work in a bipartisan way to deal with big problems, such as high drug costs. That reminder “reinforces my belief that the bipartisan Finance Committee process to lower prescription drug costs can also be successful,” Grassley said. He said...